Table 4. Comparison of biochemical and treatment factors associated with outcome.

Factors	End-point		p
	NO (n = 56)	YES (n = 23)
Complement C3 at biopsy	1.05±0.41	1.23±0.62	0.311
Low complement C3 at biopsy (%)	14.3	17.4	0.706
Complement C4 at biopsy	0.36±0.33	0.37±0.19	0.891
Low complement C4 at biopsy (%)	-	-	-
Serum cholesterol (mmol/L)	6.1±1.4	7.9±3.2	0.079
Serum albumin at biopsy (g/L)	26.1±6.9	25.2±8.2	0.667
Serum creatinine at biopsy (µmol/L)	124.7±86.9	315.2±229.0	0.001
Estimated MDRD GFR at biopsy (ml/min)	75.3±30.6	40.5±34.0	<0.0001
Proteinuria at biopsy (g/day)	8.1±6.9	8.3±5.2	0.872
Treatment with ACE-i/ARB (%)	92.9	87.0	0.409
Treatment with prednisone (%)	25.0	52.2	0.034
Treatment with cyclophosphamide (%)	8.9	26.1	0.071
Treatment with Azathioprine (%)	3.6	8.7	0.635

MDRD – Modification of Diet in Renal Disease; GFR – Glomerular filtration rate; ACE-I – Angiotensin converting enzyme inhibitors; ARB – Angiotensin receptor blockers.